Incyclix Bio
Phase 1/2ARC Therapeutics Oncology Therapeutics
Founded
2019
Focus
Small Molecules
About
ARC Therapeutics Oncology Therapeutics
Funding History
2Total raised: $43M
Series A$35MAtlas VentureMar 15, 2022
Seed$8MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2019
LocationDurham, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile